NCCN 2013 Biomarkers Congress Webinar Series: Which Disease Sites Have Data on Clinical Usefulness?

March 5, 2013

Biomarkers now play a key role in the routine management of patients with cancer and guide drug development in the age of targeted therapy.This webinar series will address the demand for reliable, practical information about biomarkers and their appropriate use, biomarker testing, application of test results, and clinical utility of biomarkers.

 

Register now!

 

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Describe the factors considered in the evaluation of the clinical usefulness of a tumor marker in oncology
  • Define, in general, the concept of clinical usefulness as applied to cancer biomarker tests
  • Identify disease areas where data supports the use of biomarker tests
Additional information
Supporters: 

This activity is supported by educational grants from Abbott; Astellas Scientific and Medical Affairs, Inc.; Genentech; Novartis Pharmaceuticals Corporation; and Veridex, LLC.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
03/05/2013
Course expires: 
05/17/2013
Event starts: 
03/05/2013 - 12:00pm EST
Event ends: 
03/05/2013 - 1:00pm EST
Cost:
$0.00
Add to calendar: 

Alan P. Venook, MD
UCSF Medical Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Price

Cost:
$0.00
Please login or register to take this course.